Wednesday, July 8, 2026

pharma · Cocaine-Related Disorders · Cocaine Dependence · DRUG

BRIGHT MINDS BIOSCIENCES

News and analysis for BRIGHT MINDS BIOSCIENCES on NovaPharmaNews — regulatory, clinical, and market coverage.

19 Vestry St, New York, NY 10013, US HQ
12 Employees
Public company Type
DRUG · NYSE Ticker
Company details
Status
Public
HQ
19 Vestry St, New York, NY 10013, US
Employees
12
Programs
1063
Drugs
444
Patents
57
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning BRIGHT MINDS BIOSCIENCES — regulatory, clinical, and market coverage.

News and analysis for BRIGHT MINDS BIOSCIENCES on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning BRIGHT MINDS BIOSCIENCES yet.

Back to company overview →